Sirio Pharma Co., Ltd. (300791.SZ) SHZ
18.14
+0.25(+1.40%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.9B |
| Enterprise Value | 8.87B |
| P/E Ratio | 45.7 |
| PEG Ratio | -0.65 |
| Price/Sales Ratio | 1.26 |
| Price/Book Ratio | 1.82 |
| Enterprise/Revenue | 1.51 |
| Enterprise/EBITDA | 50.88 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 4.26B |
| Revenue/Share | 14.14 |
| Gross Profit | 1.3B |
| EBITDA | 354.56M |
| Net Income | 136.53M |
| Diluted EPS | 0.45 |
Balance Sheet
| Total Cash | 669.31M |
| Total Cash/Share | 2.2 |
| Total Debt | 1.71B |
| Total Debt/Equity | 0.58 |
| Current Ratio | 1.85 |
| Book Value Per Share | 9.73 |
Price History
| 52-Week Change | -27.86 |
| 52-Week High | 28.19 |
| 52-Week Low | 16.81 |
| Moving Average 50 Days | 19.45 |
| Moving Average 200 Days | 22.51 |
Statistics
| Average Volume | 2.12M |
| Shares Outstanding | 308.69M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 1.53 |
| Last Split Factor | 13:10 |
| Last Split Date | June 21, 2024 |
